Dr. Prat is the Director Hospital Clinic´s Cancer and Blood Disorders Institute in Barcelona (Spain), Professor of Medicine at the University of Barcelona (UB) and Head of the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Furthermore, Dr. Prat is the Head of the Breast Cancer program at IOB-QuironSalud. In 2022, he co-founded the spin-off company called Reveal Genomics, which has developed the HER2DX® diagnostic genomic test recognized by TIME as one of the best inventions of 2022. Dr. Prat also directs the Chair of Innovation in Precision Oncology at the UB where he is a professor. Over his career, Dr Prat has obtained world-wide recognition as a prestigious clinical scientist in the field of breast cancer, genomics, and biomarker development. He has actively participated in >250 peer-reviewed articles, and he has supervised seven PhD students.